Health Delivery


WINGS GDM publications

Encontrar una cura: ¿Debería ser nuestro principal objetivo en la diabetes tipo 1?

Should a cure be our primary target for type 1 diabetes?

It is possible, of course, to quibble with the wording of the International Diabetes Federation’s (IDF) mission statement in that “a cure” (singular) for diabetes is highly unlikely ever to be achieved, despite all our best efforts.

Diapedia: a better way of learning about diabetes

Global “food insecurity” report

Diabetes Voice asked three representatives from the International Diabetes Federation’s (IDF) Young Leaders in Diabetes Programme (YLD) to report on the issue of “food insecurity” and its effect on children in their home countries. Food insecurity may be defined as the state of being without reliable access to a sufficient quantity of affordable, nutritious food.

Getting it right for kids with diabetes – everywhere

Type 1 diabetes is one of the most common chronic diseases in childhood, and the number of children developing type 1 diabetes is growing rapidly. Overall, type 1 diabetes in children worldwide is increasing 3% annually (79,100), with the greatest incidence documented in Europe and the North America and Caribbean Region.

Assurer une prise en charge efficace des personnes atteintes de diabète LADA

Le diabète sous toutes ses formes est l'une des maladies non transmissibles les plus prévalentes, avec des millions de personnes affectées à travers le monde. Pour 2013, la Fédération Internationale du Diabète estime à 8,3 % le nombre d'adultes ou à 382 millions le nombre de personnes actuellement atteintes d'une forme ou l'autre de diabète. Ce nombre devrait dépasser les 592 millions d'ici 2025.

Getting it right for people with LADA

In all its forms, diabetes is one of the most prevalent non-communicable diseases affecting millions of people around the world. For 2013, the International Diabetes Federation estimates that 8.3 percent of adults or 382 million people are currently living with one form of diabetes or another. This number is projected to rise beyond 592 million by 2025. At the present time, the burden of diabetes is severe causing a range of preventable complications and resulting in more than five million deaths each year.1

Getting it right for people with MODY

The overwhelming majority of the estimated 382 million people currently living with diabetes worldwide1 are among that number as a result of complex interactions between their genes and their environments. Certainly for the majority of those with type 2 diabetes and probably also for those with type 1 diabetes, genetic predisposition is the result of many genes.  It is polygenic. For a minority of the 382 million, however, diabetes is the result of a single gene.

Es el momento de hacer más por la diabetes: la inercia clínica y como combatirla

En el estudio de la física, el término "inercia" describe la resistencia al movimiento. Cuando se aplica a la medicina, la palabra inercia describe, de modo similar, la resistencia al cambio. Más concretamente, es la diferencia entre la atención médica a la que se debería aspirar y la que se logra en realidad. Los estudios han demostrado que la inercia clínica es un problema frecuente en el tratamiento de la diabetes tipo 21 (Cuadro 1).